Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Abbott Laboratories Stock Quote

Abbott Laboratories (NYSE: ABT)

$119.46
(0.4%)
$0.44
Price as of February 23, 2024, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Abbott Laboratories Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
ABT +16.49% +56.92% +9.42% +2,784%
S&P +26.83% +82.22% +12.74% +1,315%

Abbott Laboratories Company Info

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

News & Analysis

The Fool has written over 1,000 articles on Abbott Laboratories.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.